Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global mRNA Vaccines & Therapeutics Market Size Analysis from 2022 to 2027

1.5.1 Global mRNA Vaccines & Therapeutics Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global mRNA Vaccines & Therapeutics Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global mRNA Vaccines & Therapeutics Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: mRNA Vaccines & Therapeutics Industry Impact

Chapter 2 Global mRNA Vaccines & Therapeutics Competition by Types, Applications, and Top Regions and Countries

2.1 Global mRNA Vaccines & Therapeutics (Volume and Value) by Type

2.1.1 Global mRNA Vaccines & Therapeutics Consumption and Market Share by Type (2016-2021)

2.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2016-2021)

2.2 Global mRNA Vaccines & Therapeutics (Volume and Value) by Application

2.2.1 Global mRNA Vaccines & Therapeutics Consumption and Market Share by Application (2016-2021)

2.2.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Application (2016-2021)

2.3 Global mRNA Vaccines & Therapeutics (Volume and Value) by Regions

2.3.1 Global mRNA Vaccines & Therapeutics Consumption and Market Share by Regions (2016-2021)

2.3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global mRNA Vaccines & Therapeutics Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global mRNA Vaccines & Therapeutics Consumption by Regions (2016-2021)

4.2 North America mRNA Vaccines & Therapeutics Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia mRNA Vaccines & Therapeutics Sales, Consumption, Export, Import (2016-2021)

4.4 Europe mRNA Vaccines & Therapeutics Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia mRNA Vaccines & Therapeutics Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia mRNA Vaccines & Therapeutics Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East mRNA Vaccines & Therapeutics Sales, Consumption, Export, Import (2016-2021)

4.8 Africa mRNA Vaccines & Therapeutics Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania mRNA Vaccines & Therapeutics Sales, Consumption, Export, Import (2016-2021)

4.10 South America mRNA Vaccines & Therapeutics Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America mRNA Vaccines & Therapeutics Market Analysis

5.1 North America mRNA Vaccines & Therapeutics Consumption and Value Analysis

5.1.1 North America mRNA Vaccines & Therapeutics Market Under COVID-19

5.2 North America mRNA Vaccines & Therapeutics Consumption Volume by Types

5.3 North America mRNA Vaccines & Therapeutics Consumption Structure by Application

5.4 North America mRNA Vaccines & Therapeutics Consumption by Top Countries

5.4.1 United States mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

5.4.2 Canada mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

5.4.3 Mexico mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

Chapter 6 East Asia mRNA Vaccines & Therapeutics Market Analysis

6.1 East Asia mRNA Vaccines & Therapeutics Consumption and Value Analysis

6.1.1 East Asia mRNA Vaccines & Therapeutics Market Under COVID-19

6.2 East Asia mRNA Vaccines & Therapeutics Consumption Volume by Types

6.3 East Asia mRNA Vaccines & Therapeutics Consumption Structure by Application

6.4 East Asia mRNA Vaccines & Therapeutics Consumption by Top Countries

6.4.1 China mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

6.4.2 Japan mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

6.4.3 South Korea mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

Chapter 7 Europe mRNA Vaccines & Therapeutics Market Analysis

7.1 Europe mRNA Vaccines & Therapeutics Consumption and Value Analysis

7.1.1 Europe mRNA Vaccines & Therapeutics Market Under COVID-19

7.2 Europe mRNA Vaccines & Therapeutics Consumption Volume by Types

7.3 Europe mRNA Vaccines & Therapeutics Consumption Structure by Application

7.4 Europe mRNA Vaccines & Therapeutics Consumption by Top Countries

7.4.1 Germany mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

7.4.2 UK mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

7.4.3 France mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

7.4.4 Italy mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

7.4.5 Russia mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

7.4.6 Spain mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

7.4.7 Netherlands mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

7.4.8 Switzerland mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

7.4.9 Poland mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

Chapter 8 South Asia mRNA Vaccines & Therapeutics Market Analysis

8.1 South Asia mRNA Vaccines & Therapeutics Consumption and Value Analysis

8.1.1 South Asia mRNA Vaccines & Therapeutics Market Under COVID-19

8.2 South Asia mRNA Vaccines & Therapeutics Consumption Volume by Types

8.3 South Asia mRNA Vaccines & Therapeutics Consumption Structure by Application

8.4 South Asia mRNA Vaccines & Therapeutics Consumption by Top Countries

8.4.1 India mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

8.4.2 Pakistan mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

8.4.3 Bangladesh mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia mRNA Vaccines & Therapeutics Market Analysis

9.1 Southeast Asia mRNA Vaccines & Therapeutics Consumption and Value Analysis

9.1.1 Southeast Asia mRNA Vaccines & Therapeutics Market Under COVID-19

9.2 Southeast Asia mRNA Vaccines & Therapeutics Consumption Volume by Types

9.3 Southeast Asia mRNA Vaccines & Therapeutics Consumption Structure by Application

9.4 Southeast Asia mRNA Vaccines & Therapeutics Consumption by Top Countries

9.4.1 Indonesia mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

9.4.2 Thailand mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

9.4.3 Singapore mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

9.4.4 Malaysia mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

9.4.5 Philippines mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

9.4.6 Vietnam mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

9.4.7 Myanmar mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

Chapter 10 Middle East mRNA Vaccines & Therapeutics Market Analysis

10.1 Middle East mRNA Vaccines & Therapeutics Consumption and Value Analysis

10.1.1 Middle East mRNA Vaccines & Therapeutics Market Under COVID-19

10.2 Middle East mRNA Vaccines & Therapeutics Consumption Volume by Types

10.3 Middle East mRNA Vaccines & Therapeutics Consumption Structure by Application

10.4 Middle East mRNA Vaccines & Therapeutics Consumption by Top Countries

10.4.1 Turkey mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

10.4.3 Iran mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

10.4.5 Israel mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

10.4.6 Iraq mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

10.4.7 Qatar mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

10.4.8 Kuwait mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

10.4.9 Oman mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

Chapter 11 Africa mRNA Vaccines & Therapeutics Market Analysis

11.1 Africa mRNA Vaccines & Therapeutics Consumption and Value Analysis

11.1.1 Africa mRNA Vaccines & Therapeutics Market Under COVID-19

11.2 Africa mRNA Vaccines & Therapeutics Consumption Volume by Types

11.3 Africa mRNA Vaccines & Therapeutics Consumption Structure by Application

11.4 Africa mRNA Vaccines & Therapeutics Consumption by Top Countries

11.4.1 Nigeria mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

11.4.2 South Africa mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

11.4.3 Egypt mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

11.4.4 Algeria mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

11.4.5 Morocco mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

Chapter 12 Oceania mRNA Vaccines & Therapeutics Market Analysis

12.1 Oceania mRNA Vaccines & Therapeutics Consumption and Value Analysis

12.2 Oceania mRNA Vaccines & Therapeutics Consumption Volume by Types

12.3 Oceania mRNA Vaccines & Therapeutics Consumption Structure by Application

12.4 Oceania mRNA Vaccines & Therapeutics Consumption by Top Countries

12.4.1 Australia mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

12.4.2 New Zealand mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

Chapter 13 South America mRNA Vaccines & Therapeutics Market Analysis

13.1 South America mRNA Vaccines & Therapeutics Consumption and Value Analysis

13.1.1 South America mRNA Vaccines & Therapeutics Market Under COVID-19

13.2 South America mRNA Vaccines & Therapeutics Consumption Volume by Types

13.3 South America mRNA Vaccines & Therapeutics Consumption Structure by Application

13.4 South America mRNA Vaccines & Therapeutics Consumption Volume by Major Countries

13.4.1 Brazil mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

13.4.2 Argentina mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

13.4.3 Columbia mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

13.4.4 Chile mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

13.4.5 Venezuela mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

13.4.6 Peru mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

13.4.8 Ecuador mRNA Vaccines & Therapeutics Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in mRNA Vaccines & Therapeutics Business

14.1 Moderna Therapeutics

14.1.1 Moderna Therapeutics Company Profile

14.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Specification

14.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 eTheRNA

14.2.1 eTheRNA Company Profile

14.2.2 eTheRNA mRNA Vaccines & Therapeutics Product Specification

14.2.3 eTheRNA mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 BioNTech

14.3.1 BioNTech Company Profile

14.3.2 BioNTech mRNA Vaccines & Therapeutics Product Specification

14.3.3 BioNTech mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 CureVac

14.4.1 CureVac Company Profile

14.4.2 CureVac mRNA Vaccines & Therapeutics Product Specification

14.4.3 CureVac mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 In-Cell-Art

14.5.1 In-Cell-Art Company Profile

14.5.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Specification

14.5.3 In-Cell-Art mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Translate Bio

14.6.1 Translate Bio Company Profile

14.6.2 Translate Bio mRNA Vaccines & Therapeutics Product Specification

14.6.3 Translate Bio mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Tiba Biotechnology

14.7.1 Tiba Biotechnology Company Profile

14.7.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Specification

14.7.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Argos Therapeutics

14.8.1 Argos Therapeutics Company Profile

14.8.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Specification

14.8.3 Argos Therapeutics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Sangamo Therapeutics

14.9.1 Sangamo Therapeutics Company Profile

14.9.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Specification

14.9.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Ethris

14.10.1 Ethris Company Profile

14.10.2 Ethris mRNA Vaccines & Therapeutics Product Specification

14.10.3 Ethris mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global mRNA Vaccines & Therapeutics Market Forecast (2022-2027)

15.1 Global mRNA Vaccines & Therapeutics Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global mRNA Vaccines & Therapeutics Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global mRNA Vaccines & Therapeutics Value and Growth Rate Forecast (2022-2027)

15.2 Global mRNA Vaccines & Therapeutics Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global mRNA Vaccines & Therapeutics Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global mRNA Vaccines & Therapeutics Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America mRNA Vaccines & Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia mRNA Vaccines & Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe mRNA Vaccines & Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia mRNA Vaccines & Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia mRNA Vaccines & Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East mRNA Vaccines & Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa mRNA Vaccines & Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania mRNA Vaccines & Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America mRNA Vaccines & Therapeutics Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global mRNA Vaccines & Therapeutics Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global mRNA Vaccines & Therapeutics Consumption Forecast by Type (2022-2027)

15.3.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2022-2027)

15.3.3 Global mRNA Vaccines & Therapeutics Price Forecast by Type (2022-2027)

15.4 Global mRNA Vaccines & Therapeutics Consumption Volume Forecast by Application (2022-2027)

15.5 mRNA Vaccines & Therapeutics Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology